Objective:

To evaluate the feasibility and safety of a novel femoral artery compression hemostasis device during proximal femoral nail anti-rotation (PFNA) surgery for intertrochanteric fractures, addressing the challenge of intraoperative blood loss.

Key Findings:

• The device effectively controlled regional blood flow, indicated by the absence of the dorsalis pedis artery pulse, suggesting successful arterial compression.
• Intraoperative visible blood loss was estimated at 50 mL, which is relatively low for this type of surgery.
• Total perioperative blood loss was calculated at 433 mL, with hidden blood loss accounting for 383 mL, highlighting the importance of monitoring both visible and hidden losses.
• No postoperative complications were reported, and the patient was discharged in good condition after 6 days, indicating a favorable outcome.

Interpretation:

The application of the femoral artery compression hemostatic device was associated with reduced intraoperative blood loss and a favorable safety profile, suggesting it may be a viable alternative to traditional methods.

Limitations:

• This study is based on a single case, limiting the generalizability of the findings and introducing potential biases.
• Further studies are required to confirm the efficacy and safety of the device in a larger cohort.

Conclusion:

The femoral artery compression hemostatic device may offer a novel, non-invasive hemostatic strategy for selected hip fracture surgeries; however, further research is essential to validate these findings.